SCHEMBL21781922

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N(C)Cc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](NC(=O)CCC(=O)N2CCC(C(N)=O)CC2)C(C)C)cc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	CYP3A4	P08684	1/20	0.52

▸	FOLH1	Q04609	3/20	0.48

▸	TTR	P02766	2/20	0.44

▸	SSTR2	P30874	2/20	0.38

▸	NECTIN4	Q96NY8	1/20	0.36

▸	FAP	Q12884	2/20	0.35

▸	AKT1	P31749	1/20	0.32

▸	CTSD	P07339	1/20	0.32

▸	CTSE	P14091	1/20	0.32

▸	BACE1	P56817	1/20	0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL22068086	0.97	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21782009	0.97	CYP3A4 (0.51)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068099	0.96	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21781792	0.94	CYP3A4 (0.49)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068144	0.94	CYP3A4 (0.51)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21781877	0.94	CYP3A4 (0.51)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL21781880	0.94	CYP3A4 (0.51)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068457	0.93	CYP3A4 (0.50)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068542	0.93	CYP3A4 (0.52)	CYP3A4FOLH1TTRSSTR2NECTIN4
SCHEMBL22068458	0.92	CYP3A4 (0.53)	CYP3A4FOLH1TTRSSTR2NECTIN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3617221-A1	CYTOTOXIN AND CONJUGATE, USES OF SAME, AND PREPARATION METHOD THEREFOR	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN)	2020-03-04	—	—	EP	disclosed